Tabiora, Aisa Y.
HRN: 20-07-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2022
CEFUROXIME 500MG (TAB)
10/14/2022
10/21/2022
ORAL
1 Tab
BID
S/P NSVD With Repair Of Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Multiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes